J. Alex Mazzone is a graduate of Quinnipiac University where he obtained his B.S. in Health Science. While at Quinnipiac he worked with Dr. Alexandre DeLencastre in his research of Huntington’s disease and Alzheimer’s. Alex joined the OGI in 2015 where he uses his expertise in DNA isolation, Sanger sequencing, next-generation sequencing and microarray technologies to help OGI clinicians and researchers diagnose and understand the underlying genetic mechanisms of inherited eye disease.
Dr. Daniela Pignatta earned her PhD in Plant Pathology from University of Bologna, Italy, and did her post-doctoral training at UC Davis Genome Center, UC Berkeley and at the Whitehead Institute for Biomedical Research extensively using next generation sequencing to investigate gene expression and regulation, epigenetics and imprinting. Most recently, Daniela worked in biotech, serving as a Core team lead to support R&D operations such as QC, Sanger sequencing, NGS and microbe detection assays.
Daniela joined the Ocular Genomics Institute in March 2020 as Associate Director of Genomics Core Lab.